Guttman M - Search Results

1

Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.

Boileau I, Warsh JJ, Guttman M, Saint-Cyr JA, McCluskey T, Rusjan P, Houle S, Wilson AA, Meyer JH, Kish SJ. Boileau I, et al. Among authors: guttman m. Mov Disord. 2008 Sep 15;23(12):1776-80. doi: 10.1002/mds.22212. Mov Disord. 2008. PMID: 18661545

2

Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa.

Guttman M, Léger G, Reches A, Evans A, Kuwabara H, Cedarbaum JM, Gjedde A. Guttman M, et al. Mov Disord. 1993 Jul;8(3):298-304. doi: 10.1002/mds.870080308. Mov Disord. 1993. PMID: 8341294

3

Brain proteasomal function in sporadic Parkinson's disease and related disorders.

Furukawa Y, Vigouroux S, Wong H, Guttman M, Rajput AH, Ang L, Briand M, Kish SJ, Briand Y. Furukawa Y, et al. Among authors: guttman m. Ann Neurol. 2002 Jun;51(6):779-82. doi: 10.1002/ana.10207. Ann Neurol. 2002. PMID: 12112087

4

Current concepts in the diagnosis and management of Parkinson's disease.

Guttman M, Kish SJ, Furukawa Y. Guttman M, et al. CMAJ. 2003 Feb 4;168(3):293-301. CMAJ. 2003. PMID: 12566335 Free PMC article. Review.

5

Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.

Fitzmaurice PS, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Fitzmaurice PS, et al. Among authors: guttman m. Mov Disord. 2003 Sep;18(9):969-76. doi: 10.1002/mds.10486. Mov Disord. 2003. PMID: 14502663

6

Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

Tong J, Fitzmaurice PS, Ang LC, Furukawa Y, Guttman M, Kish SJ. Tong J, et al. Among authors: guttman m. Ann Neurol. 2004 Jan;55(1):125-9. doi: 10.1002/ana.10814. Ann Neurol. 2004. PMID: 14705122

7

Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.

Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y. Kish SJ, et al. Among authors: guttman m. Brain. 2008 Jan;131(Pt 1):120-31. doi: 10.1093/brain/awm239. Epub 2007 Oct 22. Brain. 2008. PMID: 17956909

8

Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?

Boileau I, Rusjan P, Houle S, Wilkins D, Tong J, Selby P, Guttman M, Saint-Cyr JA, Wilson AA, Kish SJ. Boileau I, et al. Among authors: guttman m. J Neurosci. 2008 Sep 24;28(39):9850-6. doi: 10.1523/JNEUROSCI.3008-08.2008. J Neurosci. 2008. PMID: 18815269 Free PMC article.

9

Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.

Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ. Boileau I, et al. Among authors: guttman m. Brain. 2009 May;132(Pt 5):1366-75. doi: 10.1093/brain/awn337. Epub 2009 Jan 19. Brain. 2009. PMID: 19153147

10

Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.

Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y. Tong J, et al. Among authors: guttman m. Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10. Brain. 2010. PMID: 19903734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters